Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
October 2016—BrandTech Scientific featured its line of Brand liquid handling products, including the Transferpette S single and multichannel pipettes optimized for handling sensitive clinical samples. The pipettes are designed for ergonomic, one-handed volume adjustment, are completely user serviceable and fully autoclavable, and are CE-IVD compliant.
October 2016—LGC Maine Standards announced its Validate D-Dimer calibration verification/linearity test kit has received 510(k) clearance for use on Instrumentation Laboratory’s ACL Top hemostasis test systems.
October 2016—Siemens Healthineers unveiled the Atellica Solution, a flexible immunoassay and clinical chemistry solution featuring patented bi-directional magnetic sample-transport technology that is 10 times faster than conventional conveyors, according to the company.
October 2016—Boston-based Oncolab’s AMAS test detects circulating antibodies to a specific antigen (protein) produced by most types of cancer. The AMAS test can be used as a diagnostic aid in cancer occurrence and recurrence. More than 60,000 tests have been performed, and both its sensitivity and specificity are over 90 percent.
October 2016—Fio Corp. exhibited the Fionet platform, a cloud-based connectivity and reporting platform that enables real-time oversight, fragile network connectivity, and actionable insights for medical device manufacturers and health care providers.
October 2016—Binding Site’s Immunological Group announced the addition of two rubella antigens and a cytomegalovirus antigen along with the availability of special protein reagents to in vitro diagnostic manufacturers.
The rubella antigens are derived and sourced from infected cells, via culture, which are then treated by UV irradiation to inactivate the pathogenic components. The ultra-purified and ultra-sensitive variant is ideal for the detection of IgM antibodies. The antigens are designed to benefit the needs of biopharmaceutical, clinical, and life science researchers, as well as manufacturers of IVD test kits, and exhibit exceptional purity levels as a result of cross-flow, ultra-filtration and centrifugation techniques.
October 2016—GlycoMark has partnered with Diazyme Laboratories to offer a diabetes panel to test three different measures of glycemic control on one specimen. The panel includes assays that measure both intermediate- and long-term glucose averages (Diazyme’s Glycated Serum Protein/GSP and Enzymatic HbA1c) along with the GlycoMark test.
October 2016—DRG International showcased its Aldosterone ELISA kit for the measurement of aldosterone in serum, plasma, and urine. Aldosterone regulates levels of sodium and potassium in the body and controls blood pressure as well as fluids and electrolytes in the blood. Measurement of aldosterone levels in serum in conjunction with plasma renin levels (aldosterone/renin ratio) can be used to differentiate between primary and secondary aldosteronism, which is vital in the treatment and management of the disease. The kit is available worldwide and is for research use only in the United States.
October 2016—Beckman Coulter, an operating company of Danaher, and Augusta University (Ga.) Medical Center signed a 15-year master service agreement. The alliance aims to create innovative models of care using technology and process improvement methodologies in the laboratory setting, ultimately providing enhanced patient care and significant long-term cost savings for the medical center.
October 2016—U.K.-based Angle plc presented a poster by researchers from the University of Texas MD Anderson Cancer Center describing clinically relevant results from a study using Angle’s Parsortix cell separation system to harvest breast cancer cells in blood for subsequent molecular characterization. The research team, led by James M. Reuben, PhD, professor, Department of Hematopathology, MD Anderson Cancer Center, confirmed the ability to perform advanced molecular analysis on breast cancer cells isolated from blood samples using the Parsortix liquid biopsy technology. The researchers note the ability of the Parsortix method to harvest circulating tumor cells without the use of antibodies.
